Invenomic Capital Management LP Sells 216,482 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Invenomic Capital Management LP cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 47.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 237,663 shares of the pharmacy operator’s stock after selling 216,482 shares during the period. Invenomic Capital Management LP’s holdings in Walgreens Boots Alliance were worth $6,205,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of WBA. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Venturi Wealth Management LLC grew its position in Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. Quest Partners LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. Finally, Tyler Stone Wealth Management grew its position in Walgreens Boots Alliance by 1,280.0% during the 3rd quarter. Tyler Stone Wealth Management now owns 1,380 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 1,280 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Up 0.6 %

Shares of NASDAQ:WBA opened at $15.94 on Tuesday. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock has a fifty day simple moving average of $17.36 and a two-hundred day simple moving average of $20.76. Walgreens Boots Alliance, Inc. has a 12-month low of $14.62 and a 12-month high of $32.89. The stock has a market capitalization of $13.75 billion, a price-to-earnings ratio of -2.28, a PEG ratio of 0.99 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.16 EPS. On average, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 6.27%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.29%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on WBA shares. HSBC reissued a “reduce” rating and issued a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Bank of America cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. UBS Group cut their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Finally, Truist Financial reaffirmed a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $23.57.

Get Our Latest Analysis on Walgreens Boots Alliance

Insider Buying and Selling

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.